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Poster Session I 97physical and emotional well-being, and many declared that they felt
a beneficial effect from the use of CAM.Conclusions: It is essential
that health professionals explore the use of CAM among their can-
cer patients, educate them about potentially beneficial and proven
therapies in light of the limited available evidence of effectiveness
and potential side effects of CAM.
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PROSPECTIVE MONITORING OF NUTRITIONAL STATUS DURING THE
EARLY PHASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANS-
PLANTATION (HSCT)
Fuji, S.1, Kamiya, S.2, Kim, S.-W.1, Sugiyama, M.2, Fukuda, T.1,
Mori, S.-I.1, Kurosawa, S.1, Yokoyama, H.1, Saito, B.1,
Takahashi, T.1, Heike, Y.1, Tobinai, K.1, Tanosaki, R.1,
Kuwahara, S.2, Takaue, Y.1. 1National Cancer Center Hospital,
Chuo-ku, Tokyo, Japan; 2National Cancer Center Hospital, Chuo-ku,
Tokyo, Japan.
Background: Currently recommended measures of parenteral
nutrition (PN) after HSCT are often associated with hyperglycemia
due to corticosteroids and calcineurin inhibitors, which increases
the risk of infectious complications and mortality. This potential
risk prevents the routine use of PN. In this study, we prospectively
monitored caloric intake, changes in body compartment and bio-
chemical indices, and assessed the correlation between these factors
and clinical outcomes. Methods: Between April 2006 and August
2007, 76 patients received allogeneicHSCT in our institute.We ex-
cluded 16 patients due to progressive disease, graft failure and obvi-
ous fluid retention including engraftment syndrome, heart failure,
renal failure and liver failure. The remaining 60 patients were cate-
gorized according to the mean caloric intake from the beginning of
conditioning to day 56 or discharge: group 1 mean caloric intake
was\ basal energy expenditure (BEE, n 5 17), group 2 1.0–1.3 
BEE (n 5 34), and group 3 . 1.3  BEE (n 5 9). The median
agewas 49.5 years. There were no statistically significant differences
in the proportion of conventional or reduced-intensity conditioning
regimens among the 3 groups. Endpoints were changes in the actual
resting energy expenditure (REE), body weight (BW) and other in-
dicators of body compartments including muscle, fat and water
weight, biochemical indices (total protein, albumin, pre-albumin
and cholinesterase), clinical events including GVHD and infectious
diseases, and length of hospital stay. Results: REE was within the
range 1.0–1.2BEE in all 3 groups. In group 1, BW (7.5%),muscle
(9.1%) and fat (10.8%) were significantly decreased, whereas no sta-
tistically significant loss of BW, muscle and fat was documented in
group 2 or group 3. There was a significant correlation between
weight loss and muscle loss (r5 0.89, P\0.001), but no differences
were found in the biochemical indices, or the incidences of GVHD
and infectious diseases among the 3 groups. The length of the hos-
pital stay after HSCT was significantly longer in group 1 compared
with the other groups (74 vs 55 days, P 5 0.03). Conclusion: Pro-
spective monitoring revealed that low caloric intake was associated
with a significant weight loss, muscle loss and longer length of hos-
pitalization. Our data suggest that the patient’s clinical outcomewill
be improved if the caloric intake during the early phase after alloge-
neic HSCT is maintained over 1.0  BEE.263
CURRENT EPIDEMIOLOGY OF ORAL CANDIDA COLONIZATION IN PA-
TIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING HEMATO-
POIETIC STEM CELL TRANSPLANTATION: A LONGITUDINAL,
PROSPECTIVE STUDY
Toro, J.J.1,2, Westbrook, S.D.1,2, Kirkpatrick, W.R.2, Fothergill, A.W.2,
Patterson, T.F.1,2, Redding, S.W.1,2, Freytes, C.O.1,2. 1South Texas Vet-
erans Health Care System, San Antonio, TX; 2University of Texas
Health Science Center at San Antonio, San Antonio, TX.
Background: The epidemiology of yeast colonization and sys-
temic infection in hematopoietic stem cell transplant (HSCT) re-
cipients has changed substantially in recent years. Although
Candida albicans remains the most common yeast pathogen, non-al-
bicans Candida species are increasingly being encountered. The rou-
tine use of fluconazole and its successful use in preventing C.albicans-related colonization and infection have caused a shift to
more resistant yeast species that represent a new clinical challenge.
Objective: To follow the evolution of Candida oral colonization
throughout HSCT therapy, employing fluconazole prophylaxis,
in order to determine the current epidemiology of resistance to
this agent.Methods: In a longitudinal, prospective study we evalu-
ated a total of 55 patients with hematologic malignancies who un-
derwent HSCT (46 autologous and 9 allogeneic) and received
fungal prophylaxis with fluconazole 400 mg PO daily starting the
first day of the conditioning regimen. Samples to assess oralCandida
colonization were collected, using the swish and spit technique,
prior to the start of fluconazole prophylaxis, on transplant day
and on a weekly basis until hospital discharge. Candida species iden-
tification was performed via CHROMagar Candida and germ tube
with confirmation using API-20C. MICs were determined using
CLSI methodology by The University of Texas Health Science
Center at San Antonio Fungus Testing Laboratory. Strain differen-
tiation in selected patients was performed by PCR analysis of each
isolate.Results:Oral colonization byCandida species was identified
in 36 of 55 (65%) patients during the study period (Table 1). Thirty-
two of 36 (89%) of these patients had a positive culture during the
initial evaluation and 26 of 36 (81%) patients had more than one
positive culture despite the use of fluconazole. Seven of 55 (13%)
patients had mixed cultures. Candida species with reduced suscepti-
bility or resistance to fluconazole were seen in 10 of 55 (18%) pa-
tients. Conclusions: Despite fungal prophylaxis with systemic
fluconazole, oral colonization by Candida species remains common
in HSCT recipients. Non-Candida albicans species with decreased
susceptibility to fluconazole continue to emerge. These data suggest
that a longitudinal surveillance with oral sampling, in patients un-
dergoing HSCT, is a good mechanism to identify patients at risk
for systemic infections with fluconazole resistant yeast, and should
be further evaluated.
Table 1. Oral fungal species associated with the HSCT
Yeast Species Total PercentCandida albicans 25 57
Candida glabrata * 12 27
Candida tropicalis 3 7
Candida dubliniensis * 1 2
Candida famata 1 2
Candida krusei * 1 2
Candida parapsilosis 1 2
Saccharomyces cerevisiae 1 2*Of the 10 patients with reduced susceptibility or resistance to flu-
conazole 8 were colonized by C. glabrata, 1 by C. dubliniensis, and 1
byC. krusei . Two of the 8 patients colonized byC. glabratawere col-
onized simultaneously by 2 different strains.264
THE POPSICKLE WITH STRAWBERRY AROMA REDUCES INFUSION-RE-
LATED NAUSEA AND VOMITING DURING THE INFUSION OF CRYOPRE-
SERVED PERIPHERAL BLOOD STEM CELLS
Akgedik, K., Akdogan, S., Aksoy, S., Ozdemir, E. Hacettepe University
Institute of Oncology, Ankara, Turkey.
Background: The aim of this study was to explore the effect of
popsickle with strawberry aroma on the infusion-related toxicity
of cryopreserved autologous peripheral blood stem cells (PBSC).
Methods: We compared two groups of adult patients receiving
popsickle with strawberry aroma during infusion or not to assess
the incidences of adverse events occurring during infusion. All pa-
tients received granisetron 2  3 mg iv, lorezepam 6  1 mg po
for prophylaxis of the nausea and vomiting during conditioning
phase and infusion day. The patients had no evidence of nausea or
vomiting prior to cryopreserved PBSC infusion. The patients
with ongoing nausea or vomiting owing to conditioning regimens
and/or receiving additional anti-emetics were excluded from the
study. Results: Forty-five patients (median age 45, range; 17–75)
were given popsickle with strawberry aroma during infusion and
